Orchid Pharma touches roof on receiving European Union GMP certification

12 Jun 2018 Evaluate

Orchid Pharma is currently trading at its upper circuit limit of Rs. 7.44, up by 0.35 points or 4.94% from its previous closing of Rs. 7.09 on the BSE.

The scrip opened at Rs. 7.44 and has touched a high and low of Rs. 7.44 and Rs. 7.44 respectively. So far 73108 shares were traded on the counter.

The BSE group 'Z' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.55 on 10-Jul-2017 and a 52 week low of Rs. 6.71 on 08-Jun-2018.

Last one week high and low of the scrip stood at Rs. 7.44 and Rs. 6.71 respectively. The current market cap of the company is Rs. 66.19 crore.

The promoters holding in the company stood at 26.69%, while Institutions and Non-Institutions held 4.74% and 68.57% respectively.

Orchid Pharma has received European Union (EU) Good Manufacturing Practice (GMP) certification based on the inspection of the Orchid’s API manufacturing facility located at SIDCO Industrial Estate, Kancheepuram district, in the state of Tamil Nadu.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients and finished dosage forms. It is also engaged in research of new drugs.


Orchid Pharma Share Price

761.60 -9.00 (-1.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×